FIELD: pharmaceutics.
SUBSTANCE: group of inventions relates to inhibitors of enteropeptidase and/or trypsin. A compound or its pharmaceutically acceptable salt is claimed, having the following general formula (I): 
, where: A1 and A2, each independently, are a residue of an inhibitor having at least one type of activity selected from enteropeptidase-inhibiting activity and trypsin-inhibiting activity; Z is a bridge, which connects A1 to A2, and which is a simple bond, C6-C12 arylene group, -(CH2-CH2-O)m-CH2-CH2-, -(CH2-O-CH2)m-, -(CH2)m-(C6-C12arylene)-(CH2)m-, or -(CH2)n-; m is an integer from 1 to 6; and n is an integer from 2 to 12; A1 and A2 have certain structures. A pharmaceutical composition for inhibition of enteropeptidase and/or inhibition of trypsin is also disclosed.
EFFECT: group of inventions provides for the expansion of the arsenal of means of a specific purpose.
25 cl, 23 tbl, 37 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | 2016 |
|
RU2720205C2 |
| ANTITUMOR AGENT AND BROMODOMAIN INHIBITOR | 2017 |
|
RU2752163C2 |
| STIMULATING AGENTS OF GROWTH HORMONE SECRETION | 1996 |
|
RU2172742C2 |
| BI- AND POLYCYCLIC SUBSTITUTED ISOQUINOLINE AND ISOQUINOLINONE DERIVATIVES, USEFUL AS RHO-KINASE INHIBITORS | 2009 |
|
RU2532481C2 |
| MOLECULARLY IMPRINTED POLYMER FOR SELECTIVE CAPTURE OF ODOROUS SUBSTANCES MOLECULES | 2013 |
|
RU2731379C2 |
| CYCLIC (AZA)INDOLYSINCARBOXAMIDES, PREPARING AND USING THEM AS PHARMACEUTICAL AGENTS | 2010 |
|
RU2539574C2 |
| PYRIDAZINE COMPOUND AND HERBICIDE | 2020 |
|
RU2817020C2 |
| 6-SUBSTITUTED ISOQUINOLINES AND ISOQUINOLINONES EFFECTIVE AS Rho-KINASE INHIBITORS | 2009 |
|
RU2528229C2 |
| BIARYL DERIVATIVE AND DRUG CONTAINING IT | 2016 |
|
RU2760373C2 |
| POLYMER, METHOD OF PREPARATION THEREOF, COATED SURFACE, AND METHOD FOR COATING SURFACE | 1992 |
|
RU2167886C2 |
